Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedFeb 24, 2024
DataAggregated Company Financials
Companies13
  • 7D-5.7%
  • 3M14.7%
  • 1Y-2.0%
  • YTD2.1%

Over the last 7 days, the Life Sciences industry has dropped 1.3%, driven by a pullback from Biotage of 6.6%. However, the industry is down 3.5% over the past year. Looking forward, earnings are forecast to grow by 36% annually.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 Feb 2024kr38.7bkr16.0b-kr1,119,786,478.0042.6x-34.6x2.4x
Mon, 22 Jan 2024kr35.8bkr15.5b-kr1,393,723,683.0042.9x-25.7x2.3x
Wed, 20 Dec 2023kr38.0bkr15.5b-kr1,393,723,683.0045.8x-27.3x2.5x
Fri, 17 Nov 2023kr32.3bkr15.4b-kr1,256,647,710.0035.5x-25.7x2.1x
Sun, 15 Oct 2023kr24.0bkr15.1b-kr1,134,516,711.0033.5x-21.2x1.6x
Tue, 12 Sep 2023kr29.0bkr15.1b-kr1,133,713,072.0038.1x-25.5x1.9x
Thu, 10 Aug 2023kr31.9bkr15.1b-kr213,871,038.0046.6x-149.3x2.1x
Sat, 08 Jul 2023kr36.2bkr14.6b-kr172,476,038.0039x-209.7x2.5x
Mon, 05 Jun 2023kr40.0bkr14.6b-kr172,476,038.0039.5x-231.7x2.7x
Wed, 03 May 2023kr36.3bkr14.5b-kr138,425,792.0035.9x-262.2x2.5x
Fri, 31 Mar 2023kr32.8bkr14.6b-kr57,185,459.0032.4x-573.9x2.2x
Sun, 26 Feb 2023kr37.1bkr14.6b-kr59,147,661.0030.6x-628x2.5x
Tue, 24 Jan 2023kr39.7bkr14.2bkr943.9m38.1x42.1x2.8x
Thu, 22 Dec 2022kr38.4bkr14.1bkr944.3m39.9x40.7x2.7x
Sat, 19 Nov 2022kr37.5bkr14.1bkr944.1m40.9x39.7x2.6x
Mon, 17 Oct 2022kr33.3bkr13.5bkr750.9m50x44.4x2.5x
Wed, 14 Sep 2022kr39.3bkr13.5bkr751.3m56.5x52.3x2.9x
Fri, 12 Aug 2022kr46.1bkr13.2bkr667.8m48.5x69.1x3.5x
Sun, 10 Jul 2022kr48.1bkr13.2bkr753.4m42.1x63.8x3.6x
Tue, 07 Jun 2022kr55.5bkr13.2bkr753.4m48.3x73.7x4.2x
Thu, 05 May 2022kr51.4bkr12.8bkr744.1m47.2x69.1x4x
Sat, 02 Apr 2022kr66.4bkr11.8bkr746.3m57.6x89x5.6x
Mon, 28 Feb 2022kr53.9bkr11.9bkr747.2m44.8x72.1x4.5x
Wed, 26 Jan 2022kr60.8bkr10.8bkr786.3m41.6x77.4x5.6x
Fri, 24 Dec 2021kr87.5bkr10.8bkr786.3m59.3x111.3x8.1x
Sun, 21 Nov 2021kr89.9bkr10.8bkr788.5m56.7x114.1x8.3x
Tue, 19 Oct 2021kr94.6bkr9.9bkr853.6m55.7x110.8x9.6x
Thu, 16 Sep 2021kr102.5bkr9.9bkr853.6m61.5x120x10.4x
Sat, 14 Aug 2021kr91.6bkr9.9bkr853.6m49.3x107.3x9.3x
Wed, 09 Jun 2021kr74.6bkr8.5bkr852.0m46.2x87.5x8.8x
Tue, 02 Mar 2021kr55.1bkr7.7bkr693.0m51.6x79.5x7.2x
Price to Earnings Ratio

79.5x


Total Market Cap: kr55.1bTotal Earnings: kr693.0mTotal Revenue: kr7.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -10x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 4.6x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 28% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market0.68%
Healthcare-1.73%
Life Sciences-5.65%
Clinical Research and Equipment-5.65%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PRO Promimickr34.804.2%
+kr26.1m
104.7%PS18.9x
PEXA B PExAkr0.440.7%
+kr126.8k
-34.2%PS9.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BIOT

kr169.00

Biotage

7D

-9.3%

1Y

8.8%

AROC

kr0.39

AroCell

7D

-4.2%

1Y

-44.6%

PEXA B

kr0.44

PExA

7D

0.7%

1Y

-34.2%

BICO

kr44.96

BICO Group

7D

-5.6%

1Y

-33.9%

MAGLE

kr26.40

Magle Chemoswed Holding

7D

-5.7%

1Y

3.9%

ALIF B

kr101.40

AddLife

7D

-1.0%

1Y

-9.9%

PRO

kr34.80

Promimic

7D

4.2%

1Y

104.7%

ALPH

kr0.40

AlphaHelix Molecular Diagnostics

7D

-11.8%

1Y

-38.9%